nach oben

Supportive Care in Cancer

Erschienen in:

23.10.2017 | Commentary

Does grip strength decrease in the very early stages of hematological treatment?

verfasst von: C. G. C. Teodozio, G. V. Chaves, I. P. Arcuri, F. T. Frajacomo

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Muscle weakness in hematological cancer patients undergoing acute stages of treatment is an important concern and strong predictor of poor outcomes. However, evidence of strength loss in the very early stages of cancer treatment is not addressed. Here, we found that grip strength was compromised within the first 7 days of hematological treatment (− 2.3 kg, P = 0.002). These findings are novel in elucidating lower handgrip strength in the first week of hematological treatment and encourage additional research focusing on handgrip strength in oncology patients under initial high-dose chemotherapy routine.

Nur mit Berechtigung zugänglich

Alibhai SM, Breunis H, Timilshina N, Brignardello-Petersen R, Tomlinson G, Mohamedali H et al (2015) Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatr Oncol 6:262–271CrossRefPubMed

Warsame R, Kasi PM, Villasboas-Bisneto JC, Gallenberg D, Wolf R, Ward J et al (2016) Transition of care for inpatient hematology patients receiving chemotherapy: development of hospital discharge huddle process and effects of implementation. J Oncol Pract 12:e88–e94CrossRefPubMed

Murnane A, Keogh J, Magat F, Imbesi S, Coulombe M, Patchell S et al (2015) The impact of an inpatient hospital admission on patients’ physical functioning and quality of life in the oncology setting. J Nurs Educ Pract 5:75–82

Wall BT, Dirks ML, Snijders T, Senden JM, Dolmans J, van Loon LJ (2014) Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiologica (Oxford, England) 210:600–611CrossRef

Bodilsen AC, Pedersen MM, Petersen J, Beyer N, Andersen O, Smith LL et al (2013) Acute hospitalization of the older patient: changes in muscle strength and functional performance during hospitalization and 30 days after discharge. Am J Phys Med Rehabil 92:789–796CrossRefPubMed

Alibhai SM, O'Neill S, Fisher-Schlombs K, Breunis H, Timilshina N, Brandwein JM et al (2014) A pilot phase II RCT of a home-based exercise intervention for survivors of AML. Support Care Cancer : Off J Multinat Assoc Support Care Cancer 22:881–889CrossRef

Humphreys J, de la Maza P, Hirsch S, Barrera G, Gattas V, Bunout D (2002) Muscle strength as a predictor of loss of functional status in hospitalized patients. Nutrition 18:616–620CrossRefPubMed

Chen CH, Ho C, Huang YZ, Hung TT (2011) Hand-grip strength is a simple and effective outcome predictor in esophageal cancer following esophagectomy with reconstruction: a prospective study. J Cardiothorac Surg 6:98CrossRefPubMedPubMedCentral

Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer : Off J Multinat Assoc Support Care Cancer 21:3261–3270CrossRef

10.

Lakenman P, Ottens-Oussoren K, Witvliet-van Nierop J, van der Peet D, de van der Schueren M (2017) Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition: 884533617700862

11.

Kramer M, Heussner P, Herzberg PY, Andree H, Hilgendorf I, Leithaeuser M et al (2013) Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation. Support Care Cancer: Off J Multinat Assoc Support Care Cancer 21:1121–1129CrossRef

12.

Morishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K et al (2013) Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer: Off J Multinat Assoc Support Care Cancer 21:2161–2169CrossRef

13.

Tanaka S, Imataki O, Kitaoka A, Fujioka S, Hanabusa E, Ohbayashi Y et al (2017) Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol 143:1083–1092CrossRefPubMed

14.

Mohamedali H, Breunis H, Timilshina N, Brandwein JM, Gupta V, Minden MD et al (2012) Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia. Leuk Res 36:1241–1248CrossRefPubMed

15.

Fess EE (1992) Clinical assessment recommendations. In: JS IC (ed) American society of hand therapist, pp. 41–45

16.

Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, Bacon SL et al (2010) Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle 1:177–185CrossRefPubMedPubMedCentral

17.

Clark BC, Manini TM (2008) Sarcopenia≠dynapenia. J Gerontol Ser A, Biolog Sci Med Sci 63:829–834CrossRef

18.

Makuuchi R, Sugisawa N, Kaji S, Hikage M, Tokunaga M, Tanizawa Y et al (2017) Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol 43:210–217CrossRef

19.

Gould DW, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS (2013) Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 4:111–124CrossRefPubMed

20.

Bergenthal N, Will A, Streckmann F, Wolkewitz KD, Monsef I, Engert A et al (2014) Aerobic physical exercise for adult patients with haematological malignancies. Cochrane database Syst Rev 11:CD009075

Titel: Does grip strength decrease in the very early stages of hematological treatment?
verfasst von: C. G. C. Teodozio
G. V. Chaves
I. P. Arcuri
F. T. Frajacomo
Publikationsdatum: 23.10.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 2/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3932-0

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Does grip strength decrease in the very early stages of hematological treatment?

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Patient and provider perceptions of Internet-delivered cognitive behavior therapy for recent cancer survivors

The effect of physical activity on fatigue among survivors of colorectal cancer: a systematic review and meta-analysis

What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study

The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie